Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ENDOLOGIX INC /DE/ | 29,932 | reported | 05 Aug 2019 | tx 6+186,895 |
| ARVINAS, INC. | 23,105 | reported | 25 Jun 2025 | tx 10+126,556 |
| PROVIDENCE SERVICE CORP | 18,830 | reported | 14 Feb 2024 | tx 10+18,830 |
| GLOBUS MEDICAL INC | 15,000 | reported | 21 Jan 2026 | tx 10+88,009−17,590 |
| CVS HEALTH Corp | 7,376 | reported | 14 May 2026 | tx 4+7,376 |
| NEUROCRINE BIOSCIENCES INC | 2,624 | reported | 27 May 2026 | tx 29+82,448−42,300 |
| CENTENE CORP | 1,481.01 | reported | 31 Mar 2022 | tx 3+11,481.01 |
| Volcano CORP | 0 | reported | 17 Feb 2015 | tx 24+58,845−40,284 |
| NUVASIVE INC | 0 | reported | 01 Sept 2023 | tx 26+40,441−40,441 |
| MAGELLAN HEALTH SERVICES INC | 0 | reported | 04 Jan 2022 | tx 5+5,698−5,698 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 1,284 | 0.00 USD | deriv |
| 27 May 2026 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 2,624 | 0.00 USD | deriv |
| 21 May 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 1,659 | 0.00 USD | |
| 21 May 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 1,659 | 0.00 USD | deriv |
| 14 May 2026 | GRANT_AWARD | CVS HEALTH Corp | 1,447 | 97.15 USD | |
| 12 May 2026 | SALE | NEUROCRINE BIOSCIENCES INC | 3,810 | 155.01 USD | 10b5-1 |
| 21 Jan 2026 | GRANT_AWARD | GLOBUS MEDICAL INC | 15,000 | 0.00 USD | deriv |
| 08 Jan 2026 | SALE | GLOBUS MEDICAL INC | 2,000 | 101.10 USD | |
| 15 Dec 2025 | SALE | NEUROCRINE BIOSCIENCES INC | 5,000 | 152.23 USD | |
| 15 Dec 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 1,724 | 84.95 USD | |
| 15 Dec 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 8,276 | 92.35 USD | |
| 16 Dec 2025 | SALE | NEUROCRINE BIOSCIENCES INC | 1,190 | 155.09 USD | |
| 15 Dec 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 8,276 | 0.00 USD | deriv |
| 15 Dec 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 1,724 | 0.00 USD | deriv |
| 12 Dec 2025 | SALE | GLOBUS MEDICAL INC | 4,000 | 88.85 USD | |
| 20 Nov 2025 | GRANT_AWARD | CVS HEALTH Corp | 1,652 | 76.04 USD | |
| 25 Jun 2025 | GRANT_AWARD | ARVINAS, INC. | 16,025 | 0.00 USD | |
| 25 Jun 2025 | GRANT_AWARD | ARVINAS, INC. | 23,105 | 0.00 USD | deriv |
| 22 May 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 1,435 | 0.00 USD | |
| 21 May 2025 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 1,659 | 0.00 USD | deriv |
| 21 May 2025 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 3,305 | 0.00 USD | deriv |
| 22 May 2025 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 1,435 | 0.00 USD | deriv |
| 15 May 2025 | GRANT_AWARD | CVS HEALTH Corp | 2,077 | 60.47 USD | |
| 23 Jan 2025 | GRANT_AWARD | GLOBUS MEDICAL INC | 15,000 | 0.00 USD | deriv |
| 21 Nov 2024 | GRANT_AWARD | CVS HEALTH Corp | 2,200 | 57.10 USD |